Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000099

Chief Commercial Officer sold 1,618 shares at $28.36 ($45,886)

  • Chief Commercial Officer acquired 5,449 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Milanova Tsveta · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-28 Exercise or conversion : show line 1 in the form 10b5-1 +5,449 5,449 D
2023-06-30 Sale : show line 2 in the form 10b5-1 −1,618 $28.36 $45,886 3,831 D
Open-market sales · 1,618 sh · avg $28.36 · $45,886

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-28 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −5,449 5,448 D
Loading xslF345X04/wk-form4_1688155347.xml…